News

Researchers from the University of Bonn and DZNE uncover the role of brain inflammation in spastic paraplegia type 15, offering new therapeutic possibilities.

In a groundbreaking discovery, researchers at the Mayo Clinic have identified specific brain cell changes that may explain the involuntary tics characteristic of Tourette syndrome.

New research uncovers important genetic clues that may help predict treatment resistance in focal epilepsy.

In a major step forward for children affected by rare genetic epilepsies, researchers from the Epilepsy Neurogenetics Initiative (ENGIN) at Children's Hospital of Philadelphia (CHOP) have completed the most comprehensive study yet on SCN8A-related disorders.

A new study from the University of Michigan is breaking fresh ground by using artificial intelligence to better support neurodivergent children in physical activity programs.

A major step forward in mitochondrial medicine has been announced by researchers at the University of Gothenburg, with the potential to pave the way for the first treatment targeting diseases caused by genetic defects in cellular energy production.

Mayo Clinic researchers pioneer AI-driven, patient-centered therapy

For decades, the thalamus — the brain’s deep-seated relay hub — has remained largely in the shadows, eclipsed by the celebrated cerebral cortex and hippocampus in discussions of memory and cognitive development.